DOW borrowing costs jump as retail attention spikes
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Dow Inc. is the lightest-shorted name among its closest peers, yet its borrowing costs just surged 79% in a week.
Short interest at Dow sits at 4.16% of free float, below the 5.2% level from a month ago and lower than most of the commodity chemicals peer group after a week of active covering. LYB carries higher short positioning; OLN and WLK are also more crowded. Dow's own position is at a two-month low, driven by bears covering after the October 22 Q3 earnings print sent shares up 7.3% in a session.
Borrow costs rise as shorts fall
The cost to borrow Dow shares climbed to 0.61% as of October 29, up from 0.34% a week earlier. That 79% weekly move is notable given how far short interest has retreated. Availability remains extremely loose at effectively the ceiling reading, with well over 700 million shares available in the lending pool, so there is no squeeze dynamic here. The cost move is more likely a function of the remaining short book repricing after the covering wave than any tightening of supply.
Dow is up 21% over the past month. A $33.62 close yesterday leaves it marginally below the consensus analyst target of $34.76, a gap of roughly 3%. Most covering firms, UBS, Citigroup, and RBC Capital, each raised their targets after Q3 but stopped at Neutral ratings, which limits the upside case.
Retail attention above its own norm
Wikipedia views and ORTEX stock page traffic for Dow hit 3.5 standard deviations above their own 90-day average as of October 25, per ORTEX alt data. This is an engagement signal, not a revenue indicator, but the spike coincides with the stock's post-earnings momentum.
Options market hedging into the rally
The put-call ratio reached 1.0025 on October 26, a reading 2.09 standard deviations above its 20-day mean, before settling back to 0.9877 on October 29. The 52-week range runs from 0.69 to 1.19. The recent PCR moves suggest some investors have been buying downside protection as the stock climbed rather than chasing calls. With the stock now 21% higher in a month and the next earnings date not until January 28, the level that would change the picture is the Barclays $30 target. Barclays initiated coverage with an Underweight in October and remains the clearest outlier among covering firms.
Data summary
- SI % of free float: 4.16%, down from roughly 5.2% one month ago
- Cost to borrow: 0.61%, up 79% week-on-week
- Availability: extremely loose, well above 700 million shares in lending pool
- Put-call ratio: 0.9877 (October 29); peaked at 1.0025 on October 26 (2.09 standard deviations above 20-day mean)
- Retail attention z-score: 3.48 vs own 90-day average (as of October 25)
- Consensus price target: $34.76; current close: $33.62
- Next earnings: January 28, 2027
Stocks in this article
See the live data behind this article on ORTEX.
Open DOW on ORTEX →How this article was generated
- Generated
- 30 Oct 2026, 11:19
- Data as of
- 30 Oct 2026, 11:12
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.